Leonabio Inc 's

• LONA's Stock Performance relative to its Competitors

Acumen Pharmaceuticals Inc Share Performance +115.11% One Year

Acumen Pharmaceuticals Inc Profile Acumen Pharmaceuticals Inc's business model focuses on developing innovative treatments and therapies for neurodegenerative diseases. They aim to address unmet medical needs through advanced research and cutting-edge technologies, with the goal of improving patients' lives and providing better healthcare solutions. More about Acumen Pharmaceuticals Inc 's Market Share

Coherus Oncology inc Share Performance -7.09% 30 Days

Coherus Oncology inc Profile Coherus Biosciences Inc is a biopharmaceutical company focused on developing and commercializing high-quality biosimilar therapeutics. Their business model revolves around leveraging their expertise in cell culture, protein purification, formulation development, and analytical methods to manufacture and market biosimilar products. By providing cost-effective alternatives to expensive biologic drugs, Coherus Biosciences aims to make healthcare more accessible and affordable for patients. More about Coherus Oncology inc 's Market Share

Cervomed Inc Share Performance -75.68% One Year

Cervomed Inc Profile Cervomed Inc's business model focuses on developing and commercializing medical devices to address neurological disorders. They aim to provide innovative solutions to improve the quality of life for patients suffering from conditions like chronic pain and epilepsy. Through their research and development efforts, Cervomed Inc aims to bring technologically advanced products to market, catering to the needs of healthcare professionals and patients worldwide. More about Cervomed Inc 's Market Share

Exelixis Inc Share Performance +2.83% Over The Past 5 Days

Exelixis Inc Profile Exelixis Inc's business model is focused on the discovery, development, and commercialization of innovative therapies for the treatment of cancer. More about Exelixis Inc 's Market Share

Filana Therapeutics Inc Share Performance -44.48% This Quarter

Filana Therapeutics Inc Profile Filana Therapeutics develops simufilam, a treatment for TSC-related epilepsy that targets filamin A. More about Filana Therapeutics Inc 's Market Share

Sources: Leonabio Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Wednesday, September 2, 2026 8:21 AM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Leonabio Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.